A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function
Clinical trial NCT05283746 · COMPLETED
Trial details
- NCT number
- NCT05283746
- Sponsor
- AN2 Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-21
- Primary completion
- 2022-06-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.